Background Extracorporeal photopheresis (ECP) is commonly used to treat patients with
graft‐versus‐host disease (GVHD) and lung transplant rejection (LTR) in our institution. The …

Abstract Purpose of Review Systemic sclerosis (SSc) is a life-threatening autoimmune
disease that causes debilitating skin fibrosis. The skin in SSc is easily accessible, and skin …

Abstract The American Society for Apheresis (ASFA) Committee on Clinical Applications
systematically and critically reviews published information on the use of therapeutic …

Background: Extracorporeal photochemotherapy (EXP) is an immunomodulating therapy
that has been used in a limited number of patients with systemic sclerosis (SSC) with …

Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …

The therapeutic options in systemic sclerosis (SSc) are limited mainly to the management of
complications, and decelerating fibrosis and preventing disease progression are still great …

Apheresis has developed into a common therapeutic modality. The evidence for the clinical
benefit of apheresis, however, is generally from uncontrolled and nonrandomized trials …

Photochemotherapy for systemic and localized scleroderma - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Help Search My account Sign in View PDF …

We measured serum levels of SP‐D in collagen diseases (110 cases) such as systemic
scleroderma (SSc), scleroderma spectrum disorders (SSD), systemic lupus erythematodes …

Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …